XML 53 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation (Tables)
 12 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award Total share-based compensation included as a component of selling, general and administrative expenses in our Consolidated Income Statements was as follows:
 Fiscal Year Ended June 30,
 202020192018
 (in thousands)
Share-based compensation related to:
Equity classified stock options$508 $868 $1,184 
Equity classified restricted stock4,970 5,177 5,195 
Total share-based compensation$5,478 $6,045 $6,379 
Weighted Average Assumptions for the Options Granted During the Following Fiscal Years
The Company used the following weighted-average assumptions for the options granted in fiscal years ended June 30, 2019 and 2018:

 Fiscal Year Ended June 30,
 20192018
Expected term4 years5 years
Expected volatility32.93 %30.70 %
Risk-free interest rate2.84 %2.17 %
Dividend yield0.00 %0.00 %
Weighted-average fair value per option$11.86 $10.60 
Stock Option Plans
A summary of activity under our stock option plans is presented below:

 Fiscal Year Ended June 30, 2020
 OptionsWeighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Life		Aggregate
Intrinsic
Value
Outstanding, beginning of year850,695 $37.57 
Granted during the period— — 
Exercised during the period(29,174)25.81 
Canceled, forfeited, or expired during the period(5,224)36.37 
Outstanding, end of year816,297 37.99 4.15$— 
Vested and expected to vest at June 30, 2020816,263 37.99 4.15$— 
Exercisable, end of year781,383 $38.16 4.00$— 
Unvested Shares A summary of the status of the Company’s shares subject to unvested options is presented below:
 Fiscal Year Ended June 30, 2020
 OptionsWeighted Average Exercise PriceWeighted Average
Grant Date 
Fair Value
Unvested, beginning of year102,432 $35.03 $10.78 
Granted— — — 
Vested(63,011)35.43 10.88 
Canceled or forfeited(4,507)35.90 11.00 
Unvested, end of year34,914 $34.19 $10.58 
Stock Options Outstanding The following table summarizes information about stock options outstanding and exercisable as of June 30, 2020:
 Options OutstandingOptions Exercisable
Range of Exercise PricesShares
  Outstanding		Weighted
Average
Remaining
  Contractual Life		Weighted Average
Exercise
Price		Number ExercisableWeighted Average
Exercise
Price
$26.38 - $30.49
18,731 2.4429.80 18,731 29.80 
$30.49 - $34.60
146,948 5.8334.16 112,529 34.16 
$34.60 - $38.71
371,169 3.6737.04 370,674 37.04 
$38.71 - $42.82
279,449 4.0241.83 279,449 41.83 
816,297 4.15$37.99 781,383 $38.16 
Restricted Stock Outstanding
During the fiscal year ended June 30, 2020, the Company granted 287,948 shares of restricted stock to employees and non-employee directors, all of which were issued in the form of RSUs or PUs:
 Fiscal Year Ended June 30, 2020
 Shares
granted		Date grantedGrant date
fair value		Vesting period
Employees
Certain employees based on performance204,524 November 15, 2019$35.25 
Annually over 3 years
Certain employees based upon hire14,225 December 2, 2019$35.15 
Annually over 3 years
Named executive officers based on performance42,199 January 30, 2020$35.19 January 1, 2020 through December 31, 2022
Non-Employee Directors
Certain Directors22,200 November 15, 2019$35.25 
6 months
Certain Director based upon appointment700 November 15, 2019$35.25 
6 months
Certain Director based upon appointment4,100 May 14, 2020$21.58 
6 months
A summary of the status of the Company’s outstanding restricted stock is presented below:

 Fiscal Year Ended June 30, 2020
 SharesWeighted-Average
Grant Date Fair
Value
Outstanding, beginning of year320,885 $37.28 
Granted during the period287,948 35.04 
Vested during the period(128,566)36.93 
Cancelled, forfeited, or expired during the period(41,811)36.71 
Outstanding, end of year438,456 $35.37